KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $17.1 billion.

  • Bristol Myers Squibb's Retained Earnings rose 618.75% to $17.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $17.1 billion, marking a year-over-year increase of 618.75%. This contributed to the annual value of $14.9 billion for FY2024, which is 4816.1% down from last year.
  • According to the latest figures from Q3 2025, Bristol Myers Squibb's Retained Earnings is $17.1 billion, which was up 618.75% from $16.2 billion recorded in Q2 2025.
  • In the past 5 years, Bristol Myers Squibb's Retained Earnings ranged from a high of $28.8 billion in Q4 2023 and a low of $14.9 billion during Q4 2024
  • Over the past 5 years, Bristol Myers Squibb's median Retained Earnings value was $22.6 billion (recorded in 2021), while the average stood at $21.7 billion.
  • Its Retained Earnings has fluctuated over the past 5 years, first skyrocketed by 1435.87% in 2023, then plummeted by 4816.1% in 2024.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Retained Earnings stood at $23.8 billion in 2021, then increased by 7.07% to $25.5 billion in 2022, then grew by 12.79% to $28.8 billion in 2023, then tumbled by 48.16% to $14.9 billion in 2024, then increased by 14.63% to $17.1 billion in 2025.
  • Its Retained Earnings stands at $17.1 billion for Q3 2025, versus $16.2 billion for Q2 2025 and $16.1 billion for Q1 2025.